Axatilimab in Combination with Ruxolitinib in Patients with Newly Diagnosed Chronic Graft-Versus-Host Disease: Interim Safety Analysis of a Randomized, Phase 2 study

Transplantation and Cellular Therapy 2026

View at publisher

Authors: Annie Im, Amandeep Salhotra, Albert Assad, Maureen R. Bleam, Peixin Zhang, Robert Zeiser

DOI: 10.1016/j.jtct.2025.12.370

Cited by: 0

Fields of Study & Subjects

Hematopoietic Stem Cell Transplantation Immunodeficiency and Autoimmune Disorders Autoimmune and Inflammatory Disorders Research